Asosiy kontentga oʻtish
AkademScholar
Mualliflar

Jamshid Gadoev

Soʻnggi maʼlum muassasa:
O'zbekiston Respublikasi Markaziy banki
ORCID:
0000-0003-3998-5786
3
h-indeks
1
i10-indeksi
31
Iqtiboslar
19
Asarlar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
051015200510152020142015201620172018201920212022202420262014: Nashrlar 0, Iqtiboslar 12015: Nashrlar 1, Iqtiboslar 12016: Nashrlar 0, Iqtiboslar 32017: Nashrlar 1, Iqtiboslar 22018: Nashrlar 0, Iqtiboslar 12019: Nashrlar 0, Iqtiboslar 12021: Nashrlar 16, Iqtiboslar 142022: Nashrlar 0, Iqtiboslar 22024: Nashrlar 0, Iqtiboslar 32026: Nashrlar 0, Iqtiboslar 3

Iqtibos tarixi

0510152020142015201620172018201920212022202420262014: Iqtiboslar 12015: Iqtiboslar 12016: Iqtiboslar 32017: Iqtiboslar 22018: Iqtiboslar 12019: Iqtiboslar 12021: Iqtiboslar 142022: Iqtiboslar 22024: Iqtiboslar 32026: Iqtiboslar 3

Nashr tarixi

0510152020142015201620172018201920212022202420262014: Nashrlar 02015: Nashrlar 12016: Nashrlar 02017: Nashrlar 12018: Nashrlar 02019: Nashrlar 02021: Nashrlar 162022: Nashrlar 02024: Nashrlar 02026: Nashrlar 0

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520142015201620172018201920212022202420262014: h-indeks 12015: h-indeks 12016: h-indeks 12017: h-indeks 12018: h-indeks 12019: h-indeks 12021: h-indeks 22022: h-indeks 22024: h-indeks 22026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011201315 iqtibos
  2. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study20154 iqtibos
  3. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?20213 iqtibos
  4. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–201820212 iqtibos
  5. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis20212 iqtibos
  6. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan20171 iqtibos
  7. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan20211 iqtibos
  8. Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?20211 iqtibos
  9. Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–201720211 iqtibos
  10. Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan20211 iqtibos

Hammualliflar

  1. Nargiza Parpieva17 ta umumiy asar2015–2021
  2. Andrei Dadu5 ta umumiy asar2013–2021
  3. Masoud Dara5 ta umumiy asar2013–2021
  4. Anthony Harries5 ta umumiy asar2017–2021
  5. Barno Abdusamatova5 ta umumiy asar2021
  6. Arax Hovhannesyan5 ta umumiy asar2021
  7. Kostyantyn Dumchev4 ta umumiy asar2021
  8. Oleksandr Korotych4 ta umumiy asar2021
  9. Sevak Alaverdyan4 ta umumiy asar2021
  10. Irina Liverko4 ta umumiy asar2021

Barcha hammualliflar →